Diflucan Articles
US FDA warns against use of PPI Prilosec with Plavix
18 November 2009
HalcyGen's SUBA-Itraconazole in commercial production
24 March 2008
S-P unveils landmark Noxafil data
29 January 2007
Italian drug spending rises 9.2%
20 November 2006
US FDA clears S-P's Noxafil for expanded indication
30 October 2006
S-P's antifungal Noxafil gets FDA OK
25 September 2006
S-P launches Noxafil in the UK for refractory IFI
13 February 2006
S-P's new antibiotic performs well in trials
19 December 2005
Pfizer acquires privately-held Bioren
22 August 2005
Scotland OKs Xeloda but fears in England/Wales
15 August 2005
Barrier's Hyphanox misses Ph III endpoint
11 July 2005
Vicuron amends its IND for anidulafungin
6 June 2005
Vicuron's anti-fungal "superior" to Pfizer's
14 February 2005
Teva gets FDA OK for fluconazole injection
24 January 2005
Spectrum gains first ANDA approval, for ciprofloxacin
20 September 2004
UPDATE: Warner Chilcott's Femtrace OKed in USA
30 August 2004
WHO on HIV: publishes new guidelines on PMTCT, adds four drugs to pre-qualification list
26 July 2004
Indian firms pay high cost for generics
12 July 2004
Free Pfizer drugs for HIV/ AIDS patients in Ethiopia
26 April 2004
Pfizer's Vfend cleared by FDA for new use
24 November 2003
Vicuron antifungal promising in Phase II
19 May 2003
Ranbaxy gets initial OK for generic Diflucan
12 May 2003
Gedeon Richter sees product mix improve in 2002
21 April 2003
Positive PH II results for Versicor's anidulafungin
24 March 2003
Sankyo, Fujisawa in cross-licensing deal
27 January 2003
Tokyo pharma stocks - week to Jan 20
27 January 2003
Baxter acquires ESI in $305M deal
6 January 2003
Caribbean/pharma HIV cut-price drug deal
15 July 2002
Pfizer sues Ranbaxy over generic Diflucan
10 June 2002
Pfizer antifungal drug cleared by EMEA
1 April 2002
Funding and approving new drugs in Israel's NHI basket
18 February 2002
CPMP backs Pfizer's Vfend
7 January 2002
CPMP backs Pfizer's Vfend
14 December 2001
Pfizer extends Diflucan offer
3 December 2001
Pfizer gets backing from Indian govt
26 November 2001
Pfizer's Vfend nears US aproval
8 October 2001
Pfizer offers Diflucan free to 50 countries
11 June 2001
US HMOs reveal their most-accepted drugs
5 April 2001
Pfizer's Diflucan for S Africa "within weeks"
23 February 2001
S Africa patent law goes to court March 5
23 February 2001
Cipla talks with MNCs over HIV drug offer
13 February 2001
US FDA panel backs approval of Merck & Co's antifungal Cancidas
17 January 2001
Pfizer forecasts strong revenue growth in 2001-2002 at R&D meeting
14 December 2000
S Africa OKs generic Diflucan imports
1 December 2000
S African TAC smuggles generic antiretroviral
26 October 2000
South Africa, Pfizer ponder Diflucan offer
30 June 2000
Fujisawa fiscal 1999 turnover driven by Prograf
24 May 2000
Analysts view Pfizer free medicine move
10 April 2000
S African challenge to Pfizer over Diflucan
16 March 2000
Pfizer EPS in 4th qtr rises 56%
18 January 2000
Fujisawa earnings driven by Prograf; pipeline looking healthy
15 November 1999
"Extraordinary"Viagra Sales Lift Pfizer Earnings
10 July 1998
Warnings To Be Added To US Propulsid Labeling
1 July 1998
Canadian Pharma Patent Infringement Regs In Court
18 February 1998
Apotex Victorious In Fluconazole Battle
16 February 1998
Pfizer Invests $179.6 Million In UK Facility
11 December 1997
New Antifungals Highlighted At ICAAC
13 November 1997
Pfizer Enters New Product Cycle With Strong Potential
7 August 1997
Pfizer Gets AAA Ranking From S&P
12 June 1997
Pfizer Wins Queen's Award For Export Achievement
24 April 1997
Forex Impacts Sales At Pfizer, Merck And S-P
22 April 1997
Orphan Drug Designations In Japan
7 April 1997
FDA Approves Janssen's Sporanox
10 March 1997
FDA Clears First One-Dose OTC Thrush Therapy
24 February 1997
Zocor "Will Be World's Top-Selling Drug In 2005"
13 January 1997
French Generic Market "Still Weak And Patchy"
16 December 1996
Astra's Losec "World's No One Drug In 1998-2000"
16 December 1996
S-P Antifungals Promising
14 October 1996
Fluvastatin Improves Antifungal Activity
14 October 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
Key Tendencies In the Drug Industry: A Chilean View
15 July 1996
Schering-Plough Chief Gives R&D Update
10 June 1996
Health Insurers In Massachusetts To Pay For AIDS Drugs
22 April 1996
Losec "Will Be The World's Top-Selling Drug In 2000"
26 February 1996
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
